V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014007 | 160006857 | 1.66 | 38.5 | Curative (C) | 2018-01-15 | 2018-01-31 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | DOXORUBICIN | 100541748 |
| 160014009 | 160006858 | 1.81 | 55.8 | Neo-adjuvant (N) | 2017-04-25 | 2017-05-01 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100228429 |
| 160014010 | 160006859 | null | null | Palliative (P) | 2018-12-18 | 2018-12-19 | IVADo | 02 | null | DOXORUBICIN + OLARATUMAB | 100778593 |
| 160014011 | 160006860 | 1.75 | 86.6 | Palliative (P) | 2018-12-03 | 2018-12-24 | Trial Unspecified | 02 | N | ECX | 100783308 |
| 160014014 | 160006861 | 1.7 | 90.1 | Palliative (P) | 2019-05-12 | 2019-06-08 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101046922 |
| 160014015 | 160006862 | 1.5 | 87.8 | Neo-adjuvant (N) | 2019-12-08 | 2019-12-31 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100886435 |
| 160014017 | 160006863 | 1.7 | 74 | Palliative (P) | 2020-07-16 | 2020-07-16 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101430960 |
| 160014019 | 160006864 | 1.75 | 64.6 | Palliative (P) | 2017-02-25 | 2017-03-01 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101111338 |
| 160014020 | 160006865 | 1.67 | 61 | null | null | 2018-12-13 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101493979 |
| 160014021 | 160006866 | null | null | Neo-adjuvant (N) | 2018-08-05 | 2018-08-18 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100186641 |
| 160014022 | 160006867 | 1.55 | 54.3 | Curative (C) | 2016-11-10 | 2016-11-30 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100300182 |
| 160014024 | 160006868 | 0 | 60.7 | Palliative (P) | 2019-07-31 | 2019-08-01 | DOXORUBICIN | 02 | Y | DOXORUBICIN | 100995888 |
| 160014026 | 160006869 | 1.75 | 89.2 | null | 2018-12-01 | 2018-12-14 | Cisplatin + Pemetrexed | N | Y | CISPLATIN + PEMETREXED | 100258546 |
| 160014027 | 160006870 | null | 77.2 | Palliative (P) | 2017-08-30 | 2017-09-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100976959 |
| 160014031 | 160006871 | 1.76 | 77.7 | Palliative (P) | 2018-08-23 | 2018-09-04 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100245990 |
| 160014032 | 160006872 | 1.73 | 129.1 | Palliative (P) | 2019-01-14 | 2019-01-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101215761 |
| 160014033 | 160006873 | 1.68 | 71 | null | 2018-05-27 | 2018-06-06 | Doxorubicin 75mg/m2 | 02 | N | CARBOPLATIN + GEMCITABINE | 100836716 |
| 160014034 | 160006874 | 1.59 | 62.1 | Disease modification (D) | null | 2019-12-09 | DOXORUBICIN | 02 | null | IVA | 101096506 |
| 160014036 | 160006875 | 1.58 | 58.5 | null | 2020-05-12 | 2020-05-12 | VIDE | N | N | DOXORUBICIN | 101750448 |
| 160014038 | 160006877 | null | null | Palliative (P) | 2018-11-09 | 2018-11-09 | Liposomal Doxorubicin (Caelyx) | 2 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 101230305 |
| 160014040 | 160006878 | 1.71 | 59 | Palliative (P) | 2018-07-30 | 2018-08-13 | Trial Unspecified | N | N | VINORELBINE | 101320546 |
| 160014042 | 160006879 | 1.75 | 101 | null | 2019-12-21 | 2019-12-22 | Trial Unspecified | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100927720 |
| 160014044 | 160006880 | 1.61 | 74 | Palliative (P) | 2019-03-10 | 2019-04-04 | null | 02 | N | LIPOSOMAL DOXORUBICIN | 101429281 |
| 160014045 | 160006881 | 1.5 | 71 | Palliative (P) | null | 2019-10-26 | Bevacizumab | 02 | N | CAP | 101173232 |
| 160014049 | 160006882 | 1.62 | 88.6 | Palliative (P) | 2018-06-05 | 2018-06-05 | Carboplatin AUC 2 - 5 | 2 | null | CARBOPLATIN | 100346077 |
| 160014050 | 160006883 | 1.67 | 57.6 | Adjuvant (A) | 2016-10-13 | 2016-10-13 | CHOP R - 21 days | 02 | N | PEMETREXED | 100000796 |
| 160014051 | 160006884 | 1.82 | 76.1 | Palliative (P) | 2017-03-12 | 2017-03-15 | Carboplatin + Paclitaxel (3 weekly) | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100072836 |
| 160014054 | 160006885 | 1.61 | 48.8 | Palliative (P) | null | 2017-11-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101469650 |
| 160014059 | 160006887 | 1.68 | 55 | Palliative (P) | 2016-06-14 | 2016-06-28 | VAC | 02 | N | PACLITAXEL | 101675988 |
| 160014061 | 160006888 | 0 | 55.6 | Palliative (P) | 2016-10-27 | 2016-10-27 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100986507 |
| 160014062 | 160006889 | 1.72 | 104.8 | Palliative (P) | 2016-08-27 | 2016-09-03 | Enzalutamide | 02 | null | NOT MATCHED | 100004977 |
| 160014064 | 160006891 | 1.62 | 86.6 | Adjuvant (A) | 2018-09-12 | 2018-09-15 | Doxorubicin + Olaratumab | 02 | N | BEVACIZUMAB + CARBO + PACLITAXEL | 101296044 |
| 160014065 | 160006892 | 1.59 | 80.9 | null | 2018-01-04 | 2018-01-17 | Doxorubicin + Ifosfamide | 02 | N | NB HRNBL-1 COJEC IND COURSE A | 100385879 |
| 160014066 | 160006893 | 1.73 | 90.4 | Palliative (P) | 2018-11-06 | 2018-11-07 | IVADo | Y | N | DOXORUBICIN | 101246980 |
| 160014067 | 160006894 | 1.63 | 80.2 | Palliative (P) | 2019-06-22 | 2019-07-07 | CISPLATIN + ETOPOSIDE | 02 | null | VINORELBINE | 101529819 |
| 160014070 | 160006895 | 1.73 | 89 | Palliative (P) | 2019-09-21 | 2019-09-24 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101759999 |
| 160014071 | 160006896 | 1.53 | 80 | Palliative (P) | 2016-05-14 | 2016-05-14 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100428180 |
| 160014076 | 160006897 | 1.75 | 71.1 | Palliative (P) | 2016-04-08 | 2016-04-16 | Carboplatin AUC 2 - 5 | 02 | N | NIVOLUMAB | 100239955 |
| 160014077 | 160006898 | 1.86 | 77 | Curative (C) | 2017-08-23 | 2017-09-13 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100172350 |
| 160014080 | 160006899 | 1.78 | 78 | Neo-adjuvant (N) | 2017-06-04 | 2017-06-04 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100213674 |
| 160014082 | 160006900 | 1.7 | 75.3 | Palliative (P) | 2020-01-15 | 2020-01-22 | Liposomal Doxorubicin 40mg/m2 | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101162962 |
| 160014083 | 160006901 | 1.76 | 64.7 | Palliative (P) | 2018-03-20 | 2018-03-25 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101336719 |
| 160014084 | 160006902 | 1.8 | 63 | null | 2018-09-22 | 2018-09-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101138142 |
| 160014085 | 160006903 | 1.68 | 65 | Curative (C) | 2017-10-20 | 2017-11-07 | Trial Unspecified | 02 | null | IVA | 101459657 |
| 160014087 | 160006904 | 1.82 | 71 | null | null | 2017-05-26 | Cisplatin + Pemetrexed | 2 | Y | CISPLATIN + PEMETREXED | 101088330 |
| 160014089 | 160006906 | 1.17 | 74 | Palliative (P) | 2018-12-30 | 2019-01-07 | EOX | 02 | N | PACLITAXEL | 100967448 |
| 160014092 | 160006907 | 1.58 | 74.9 | Palliative (P) | 2019-06-26 | 2019-07-02 | null | 02 | N | ATOMIC-MESO TRIAL | 100272688 |
| 160014093 | 160006908 | 1.7 | 82.1 | Curative (C) | null | 2019-09-29 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101561661 |
| 160014094 | 160006909 | 1.55 | 61 | null | 2017-03-13 | 2017-03-16 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100133327 |
| 160014095 | 160006910 | 1.64 | 60.7 | Palliative (P) | 2018-03-30 | 2018-04-13 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100020151 |